Table 2. Laboratory Findings of Patients With COVID-19.
| Laboratory finding | Median (range) | P valuea | ||
|---|---|---|---|---|
| Total (N = 214) | Severe (n = 88) | Nonsevere (n = 126) | ||
| Count, ×109/L | ||||
| White blood cell | 4.9 (0.1-20.4) | 5.4 (0.1-20.4) | 4.5 (1.8-14.0) | .008 |
| Neutrophil | 3.0 (0.0-18.7) | 3.8 (0.0-18.7) | 2.6 (0.7-11.8) | <.001 |
| Lymphocyte | 1.1 (0.1-2.6) | 0.9 (0.1-2.6) | 1.3 (0.4-2.6) | <.001 |
| Platelet | 209.0 (18.0-583.0) | 204.5 (18.0-576.0) | 219.0 (42.0-583.0) | .25 |
| C-reactive protein, mg/L | 12.2 (0.1-212.0) | 37.1 (0.1-212.0) | 9.4 (0.4-126.0) | <.001 |
| D-dimer, mg/L | 0.5 (0.1-20.0) | 0.9 (0.1-20.0) | 0.4 (0.2-8.7) | <.001 |
| Creatine kinase, U/L | 64.0 (8.8-12216.0) | 83.0 (8.8-12216.0) | 59.0 (19.0-1260.0) | .004 |
| Lactate dehydrogenase, U/L | 241.5 (2.2-908.0) | 302.0 (2.2-880.0) | 215.0 (2.5-908.0) | <.001 |
| Aminotransferase, U/L | ||||
| Alanine | 26.0 (5.0-1933.0) | 32.5 (5.0-1933.0) | 23.0 (6.0-261.0) | .04 |
| Aspartate | 26.0 (8.0-8191.0) | 34.0 (8.0-8191.0) | 23.0 (9.0-244.0) | <.001 |
| Blood urea nitrogen, mmol/L | 4.1 (1.5-48.1) | 4.6 (1.5-48.1) | 3.8 (1.6-13.7) | <.001 |
| Creatinine, μmol/L | 68.2 (35.9-9435.0) | 71.6 (35.9-9435.0) | 65.6 (39.4-229.1) | .03 |
Abbreviation: COVID-19, coronavirus disease 2019.
SI conversion factor: To convert aminotransferase levels to microkatals per liter, multiply by 0.0167; creatine kinase to microkatals per liter, multiply by 0.0167; lactate dehydrogenase to microkatals per liter, multiply by 0.0167.
a
P values indicate differences between patients with severe and nonsevere infection, and P less than .05 was considered statistically significant.